Elanco Animal Health Incorporated Common Stock vs Oklo Inc — how do they compare? Elanco Animal Health Incorporated Common Stock trades at $22.92 (market cap $11.26B), while Oklo Inc trades at $34.67 (market cap $6.43B). The key difference: Elanco Animal Health Incorporated Common Stock is the larger of the two by market cap, and Elanco Animal Health Incorporated Common Stock is trading nearer its 52-week high, Oklo Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Elanco Animal Health Incorporated Common Stock for 1 Days and Oklo Inc for 32 Days on average.
| ELAN | OKLO | |
|---|---|---|
Market Cap | $11.26B | $6.43B |
Volume | 4,570,386 | 16,238,368 |
Sector | Health | Utilities |
52-Week High | $26.84 | $174.14 |
52-Week Low | $19.76 | $34.57 |
Typical Hold Time | 1 Days | 32 Days |
Enterprise Value | $14.65B | $3.97B |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
OKLO trades at $34.70, down 5.76% in the last 24 hours, with a bearish technical signal from moving averages. The company reported no revenue in 2025 and a net loss of $105.66 million, with a negative net income margin of -12,625.54%. Recent news highlights competition in the nuclear sector and a $1 billion stock sale, while analyst consensus remains bullish with a $78.63 price target.
Outlook: High growth potential in the nuclear energy market, supported by a strong buy rating from analysts. Risks include significant cash burn, lack of revenue, and execution challenges in commercializing reactor technology. The stock's upside depends on successful project deployment and future revenue generation.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Elanco develops medicines, vaccines, and other health products for pets and livestock. Its products address prevention and treatment of animal diseases.
Read more on ELAN →Oklo Inc. is a company focused on developing and commercializing advanced fission power plants. The company specializes in micro-reactor technology, specifically the Aurora design, which uses advanced fuel to produce reliable, clean, and cost-competitive power. Oklo aims to provide scalable, on-site power solutions to various customers, including remote communities, industrial facilities, and government entities, positioning itself as an innovator in the next generation of nuclear energy.
Read more on OKLO →